10 Ways to Keep Your Heart Healthy
No one ever had fun visiting the cardiologist. ­Regardless of how good the doc might be, it’s always a little scary thinking about the health of something as fundamental as the heart. But there are ways to take greater control—to ensure that your own heart health is the best it can be—even if you have a family history of cardiovascular disease. Although 50% of cardiovascular-disease risk is genetic, the other 50% can be modified by how you live your life, according to Dr. Eugenia Gianos, director of Women’s Heart Health at Lenox Hill Hospital in New York City. “This means you can greatly ...
Source: TIME: Health - October 17, 2018 Category: Consumer Health News Authors: Lisa Lombardi and Jamie Ducharme Tags: Uncategorized Baby Boomer Health heart health Source Type: news

Abbott slips on narrowed earnings guidance
Abbott shares slipped in pre-market trading today after the company narrowed its earnings outlook for the rest of the year, after just meeting both its own forecast and the consensus Wall Street outlook. The Chicago-area healthcare giant’s profits for the three months ended Sept. 30 were off -6.6% at $563 million, or 32¢ per share, despite sales growth of 12.1% to $7.66 billion compared with Q3 2017. Adjusted to exclude one-time items, earnings per share were 75¢, dead even with the top end of Abbott’s guidance and the average on The Street, where analysts were looking for sales of $7.65 billion. &ldq...
Source: Mass Device - October 17, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured MassDevice Earnings Roundup Wall Street Beat Abbott Source Type: news

CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity
Incidence of congestive heart failure 31 percent among women with a history of cardiotoxicity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 16, 2018 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Gynecology, Oncology, Pharmacy, Radiology, Journal, Source Type: news

CHF in Pregnancy Up for Cancer Survivors With Cardiac Toxicity
TUESDAY, Oct. 16, 2018 -- The incidence of congestive heart failure (CHF) during pregnancy is 31 percent among women with a history of cardiotoxicity associated with cancer treatment, according to a study published in the Oct. 23 issue of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Women treated for cancer have higher CHF risk in pregnancy
Anthracycline-exposed women should receive close cardiac surveillance during pregnancy Related items fromOnMedica Child cancer survivors can become pregnant as adults Breast cancer during pregnancy need not harm baby Include pregnant women in studies, urge researchers Heart failure with preserved ejection fraction (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 16, 2018 Category: UK Health Source Type: news

Cancer survivors at risk for heart failure during, after pregnancy
(American College of Cardiology) Young women previously treated for cancer with chemotherapy or radiation therapy with a prior history of cardiotoxicity are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy, according to a study published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

HEALTH NOTES: Pioneering implant that can revitalise failing hearts  
A nerve-stimulating implant is to be offered to British patients with debilitating heart failure, giving hope to thousands for whom standard treatments offer no relief. (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2018 Category: Consumer Health News Source Type: news

BWH Awarded $5.6 Million Grant for NIH Heart Failure-Sleep Trial
Brigham and Women ’s Hospital received a $5.6 million grant from the National Institutes of Health (NIH) to support a multi-institutional clinical trial that will examine the use of low-flow nighttime oxygen therapy to treat central sleep apnea in pat (Source: BWH News)
Source: BWH News - October 12, 2018 Category: Hospital Management Source Type: news

BWH Wins AHA Get With The Guidelines-Heart Failure Silver Plus Quality Achievement Award
Brigham and Women ’s Hospital received the American Heart Association’s Get With The Guidelines-Heart Failure Silver Plus Quality Achievement Award. This award recognizes the hospital’s commitment to ensuring heart failure patients receive the most ap (Source: BWH News)
Source: BWH News - October 12, 2018 Category: Hospital Management Source Type: news

Heart Failure | Medscape Heart Failure | Medscape
Review in-depth clinical information, latest medical news, and guidelines on heart failure. Understand the strategies for managing congestive heart failure and heart disease, including cardiac failure diagnosis and management. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

New tool can identify heart failure patients at high risk of sepsis
A tool has been developed by UK researchers to help identify heart failure patients at high risk of sepsis, which they say could catch cases early and save thousands of lives every year. (Source: Nursing Times)
Source: Nursing Times - October 10, 2018 Category: Nursing Source Type: news

Medical News Today: Newly discovered molecule could treat heart failure
New research has discovered a molecule that plays a key role in supporting heart function. This finding may lead to better therapy for heart failure. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 10, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

‘ Take Action ’ : Dave McGillivray ’s Message To Anyone Ignoring Symptoms Of Heart Disease
BOSTON (CBS) – There aren’t many people who run their age in miles every year. Dave McGillivray does. From the time he was a boy, he’s celebrated his good health and love of running with a personal challenge that obviously gets more challenging with age. His last “full” birthday run was last year: 63 miles. This year, by necessity, he split the effort into 32 miles of running and 32 miles of biking. A feat, to be sure. But this year, he is facing a challenge for which there is no training. McGillivray, arguably one of the most fit people on the planet, has coronary artery disease and is prepa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 9, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Seen On WBZ-TV Syndicated Local Watch Listen Dave McGillivray Lisa Hughes Mass General Hospital Source Type: news

Atrial Fibrillation in Patients With Heart Failure Atrial Fibrillation in Patients With Heart Failure
Atrial fibrillation frequently coexists with heart failure and may result in increased adverse outcomes. Review therapeutic considerations and best approaches to treatment in this article.American Journal of Cardiovascular Drugs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Gene mutation points to new way to fight diabetes, obesity, heart disease
(NIH/National Heart, Lung and Blood Institute) Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. Those with the mutation have a lower risk of diabetes, obesity, heart failure, and even death. The researchers say their finding could provide the basis for drug therapies that could mimic the workings of this gene mutation, offering a potential benefit for the millions of people who suffer with diabetes, heart disease, and obesity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 9, 2018 Category: International Medicine & Public Health Source Type: news

CARMELINA: Linagliptin Reassures for DPP-4 Inhibitors in Diabetes CARMELINA: Linagliptin Reassures for DPP-4 Inhibitors in Diabetes
The CARMELINA safety study for the dipeptidyl peptidase-4 inhibitor linagliptin not only shows no increase in CV, kidney, or safety events but also allays fears over a class heart failure effect.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 8, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Medical News Today: Why are my feet swollen?
There are many explanations for why a person may have swollen feet. Some causes, such as a twisted or sprained ankle, are obvious. Others might be less apparent but need urgent medical attention. These include a blood clot in the leg, heart failure, and preeclampsia. Find out when to see a doctor for swollen feet here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 5, 2018 Category: Consumer Health News Tags: Vascular Source Type: news

No Increase in In-Hospital, Post-Discharge Death With HRRP
FRIDAY, Oct. 5, 2018 -- Announcement and implementation of the Hospital Readmissions Reduction Program (HRRP) was not associated with increases in in-hospital or post-discharge mortality after acute myocardial infarction (AMI), heart failure, or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2018 Category: Pharmaceuticals Source Type: news

CMS Penalties and 30-Day Postdischarge Metrics: Next Chapter CMS Penalties and 30-Day Postdischarge Metrics: Next Chapter
Survival didn't suffer after CMS started docking reimbursements based on 30-day readmissions related to heart failure and MI, contrary to an earlier study, an analysis of Medicare data suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

V-Wave launches pivotal interatrial shunt trial
V-Wave said today it launched a new trial of its minimally invasive interartrial shunt designed to treat patients with symptomatic heart failure. The new Relieve-HF trial aims to enroll 500 patients in a pivotal study of the device, which is designed for patients with NHYA Class III and ambulatory Class IV symptomatic heart failure, the Israel-based company said. “The interatrial shunt provides a novel therapeutic approach for patients with chronic HF. The shunt is implanted through a catheter inserted in a vein in the leg. Prior clinical experience demonstrated device and implantation procedure safety, and stat...
Source: Mass Device - October 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials V-Wave Source Type: news

Severe mental illness (SMI) and physical health inequalities: briefing
This report finds people with severe mental illness have significantly worse physical health compared to the general population, with a higher prevalence of obesity, diabetes, COPD, stroke, heart failure, coronary heart disease and asth (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 3, 2018 Category: Consumer Health News Source Type: news

Prioritizing Patients in Push Toward Value-Based Care
Previously, we discussed how medtech companies can prepare for the transition to value-based care. Specifically, these organizations need to start going beyond just providing medical devices and products to their customers and focus more on providing comprehensive and connected systems that help deliver integrated care. This, however, needs common collaboration between vendors, which are too often direct competitors and therefor pushing for their own more expensive complete solutions.   Interoperability and health data exchange have become a top priority for providers. Along with EMRs, all machines being utiliz...
Source: MDDI - October 3, 2018 Category: Medical Devices Authors: Corrina Kane Tags: Business Source Type: news

Estonia: Health System Review.
Authors: Habicht T, Reinap M, Kasekamp K, Sikkut R, Aaben L, van Ginneken E Abstract This analysis of the Estonian health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. In 2017, the Estonian government took the historic step of expanding the revenue base of the health system, which has been a longstanding challenge. However, in terms of percentage of GDP it remains a small increase and long-term financial sustainability could still pose a problem. That said, if these additional funds are invested wisely, they ...
Source: Health systems in transition - October 3, 2018 Category: Health Management Tags: Health Syst Transit Source Type: news

Cardiologist, Primary-Care Management Differs in Preserved-EF HF Cardiologist, Primary-Care Management Differs in Preserved-EF HF
Many noncardiologists manage patients with heart failure and preserved ejection fraction, a small survey suggests, yet most don't know the guidelines. Nor, surprisingly, may many cardiologists.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 1, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Perspective: A Heart Device Can Save Lives, But Doctors Need To Explain The Downsides
A mechanical pump can be life-saving for heart failure patients or it can cause dangerous complications. Doctors can do a better job at explaining the reasons some patients may want to opt out. (Image credit: 7asmin via Wikimedia Commons) (Source: NPR Health and Science)
Source: NPR Health and Science - September 30, 2018 Category: Consumer Health News Authors: Dr. Matthew Movsesian Source Type: news

12 Congestive Heart Failure Symptoms, Stages, Causes, and Life Expectancy
Title: 12 Congestive Heart Failure Symptoms, Stages, Causes, and Life ExpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/28/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 28, 2018 Category: Cardiology Source Type: news

Smarter strategies to treat atrial fibrillation
An innovative smartphone app developed in an EU-funded project is helping doctors provide thousands of heart patients across Europe with better, more personalised treatment for atrial fibrillation - a major cause of stroke, dementia, heart failure and premature death. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - September 27, 2018 Category: Research Source Type: news

New Device Offers Hope For People With Heart Failure
(CNN) — A tiny new device is offering hope of a better life for people with severe heart failure, reducing hospitalization rates and improving mortality risk within two years of treatment, a new study finds. Heart failure affects an estimated 5.7 million Americans and more than 26 million people globally, causing shortness of breath and tiredness among those affected as their heart struggles to pump blood around the body. One cause of severe heart failure that currently has a poor prognosis is a leaky valve, particularly the leakage of the mitral valve, which control’s blood flow in the left part of the heart....
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 26, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Heart Failure Local TV Source Type: news

Device offers hope for people with heart failure
A tiny new device is offering hope of a better life for people with severe heart failure, reducing hospitalization rates and improving mortality risk within two years of treatment, a new study finds. (Source: CNN.com - Health)
Source: CNN.com - Health - September 26, 2018 Category: Consumer Health News Source Type: news

COAPT Hits Sweet Spot of MitraClip Efficacy for Secondary MR COAPT Hits Sweet Spot of MitraClip Efficacy for Secondary MR
The trial drew applause at TCT but the findings contrast with those of MITRA-FR. What does this mean for the percutaneous management of secondary mitral regurgitation in patients with heart failure?theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

DECLARE-TIMI 58: HF Benefit for Dapagliflozin in Diabetes? DECLARE-TIMI 58: HF Benefit for Dapagliflozin in Diabetes?
Top-line data from DECLARE-TIMI 58 hint that CV benefit of the SGLT2 inhibitor dapagliflozin for type 2 diabetes is driven by improvement in heart failure, but 60% of patients were primary prevention.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 25, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Coronary Microvascular Dysfunction: Common Finding in HFpEF Coronary Microvascular Dysfunction: Common Finding in HFpEF
Dr Ileana Pi ñ a discusses coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction with PROMIS-HFpEF investigator Dr Carolyn Lam.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Device a 'Game Changer' for Severe Heart Failure?
The trial included 614 patients with severe heart failure in the United States and Canada. They were randomly assigned to receive either the MitraClip plus standard therapy or standard therapy alone. (Source: WebMD Health)
Source: WebMD Health - September 24, 2018 Category: Consumer Health News Source Type: news

This Medical Clip May Be a Powerful Treatment for Heart Failure, Study Says
A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, called the MitraClip, reduced hospitalizations related to heart failure by nearly half and deaths by nearly 40% among patients with a specific and serious complication of heart failure, compared to those who received standard medical treatment. The results were published Sunday in the New England Journal of Medicine. “This therapy really offers an important new option for very desperate patients who are suffering...
Source: TIME: Health - September 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Research Source Type: news

Minimally invasive procedure for valve problems reduces heart failure risk
A minimally invasive procedure significantly reduced heart failure risk among those patients with valves that don't properly connect in the heart. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 24, 2018 Category: Consumer Health News Source Type: news

New device offers hope for people with heart failure
A tiny new device is offering hope of a better life for people with severe heart failure, reducing hospitalization rates and improving mortality risk within two years of treatment, a new study finds. (Source: CNN.com - Health)
Source: CNN.com - Health - September 24, 2018 Category: Consumer Health News Source Type: news

Device Might Be 'Game Changer' for Patients With Severe Heart Failure
Title: Device Might Be 'Game Changer' for Patients With Severe Heart FailureCategory: Health NewsCreated: 9/24/2018 12:00:00 AMLast Editorial Review: 9/24/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 24, 2018 Category: Cardiology Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

COAPT Stuns, Resurrects MitraClip in HF With Mitral Regurgitation COAPT Stuns, Resurrects MitraClip in HF With Mitral Regurgitation
After a dismal showing in the recent MITRA-FR study, dramatic reductions in heart failure hospitalizations and death had even the researchers asking,'Why are the COAPT results so different? 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 24, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

MitraClip for Secondary MR -- The Redux MitraClip for Secondary MR -- The Redux
Two conflicting studies on the percutaneous treatment of secondary mitral regurgitation in patients with heart failure lead John Mandrola, MD, to compare and contrast as we await the tiebreaker third.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 23, 2018 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

Tiny Device Is a ‘ Huge Advance ’ for Treatment of Severe Heart Failure
A clip used to repair damaged heart valves sharply reduced deaths among patients with a grim prognosis. (Source: NYT Health)
Source: NYT Health - September 23, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Heart Surgery and Surgeons heart failure Source Type: news

Landmark Study Shows Treatment with Abbott's MitraClip ® is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation
- The COAPT trial met both the primary safety and efficacy endpoints and all secondary endpoints, including reducing all-cause mortality through two years (Source: Abbott.com)
Source: Abbott.com - September 23, 2018 Category: Pharmaceuticals Source Type: news

Mortality Rate From Heart Failure Higher in Women Than Men
FRIDAY, Sept. 21, 2018 -- Despite decreases in overall heart failure incidence and mortality in ambulatory patients from 2009 to 2014, mortality rates remain higher in women than in men, according to a study recently published in CMAJ, the journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2018 Category: Pharmaceuticals Source Type: news

Cardiac Monitoring Needed for High - Risk Breast Cancer Patients
Trastuzumab, certain chemo treatments increase patient risk of heart failure (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 20, 2018 Category: Cancer & Oncology Tags: Cardiology, Gynecology, Oncology, Pharmacy, Journal, Source Type: news

Health Tip: A Nutritious Diet Can Help Your Heart
-- Add another benefit to eating right: A highly nutritious diet can do wonders for your ticker, a new study published in the Journal of the American Heart Association finds. People with heart failure who lacked seven or more micronutrients had... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 20, 2018 Category: General Medicine Source Type: news

Paramedics Still Assist Puerto Rican Kidney Patients a Year After Maria
VIEQUES, Puerto Rico (AP) — As weeks turned into months, the seats of the small plane began to empty out. In the beginning, 15 passengers flew from Vieques to the Puerto Rican mainland — refugees from Hurricane Maria. The storm had ruined the only dialysis center on this tiny island, their home; without treatment, the kidney patients would die. But the thrice-weekly trips have taken a toll on these frail patients. Five have died in this past year from causes ranging from heart failure to cancer, but advocates insist that the very flights that keep the patients alive have hastened their deaths. The mortality rat...
Source: JEMS Patient Care - September 19, 2018 Category: Emergency Medicine Authors: Danica Coto, Associated Press Tags: Patient Care News Source Type: news

Paramedics Still Assist Puerto Rican Kidney Patients a Year After Maria
VIEQUES, Puerto Rico (AP) — As weeks turned into months, the seats of the small plane began to empty out. In the beginning, 15 passengers flew from Vieques to the Puerto Rican mainland — refugees from Hurricane Maria. The storm had ruined the only dialysis center on this tiny island, their home; without treatment, the kidney patients would die. But the thrice-weekly trips have taken a toll on these frail patients. Five have died in this past year from causes ranging from heart failure to cancer, but advocates insist that the very flights that keep the patients alive have hastened their deaths. The mortality rat...
Source: JEMS: Journal of Emergency Medical Services News - September 19, 2018 Category: Emergency Medicine Authors: Danica Coto, Associated Press Tags: Patient Care News Source Type: news

Cardiac Dimensions launches pivotal Carillon mitral repair device trial
Cardiac Dimensions said today it launched a pivotal trial of the Carillon mitral valve repair device it’s developing, and that it enrolled and randomized its first patient in the trial. The Kirkland, Wash.-based company’s percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral annulus by bending the coronary sinus. Late last year the FDA granted an investigational device exemption for a 400-patient pivotal trial of the Carillon device. The first patient in the trial was enrolled and ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Cardiac Dimensions Source Type: news

Cardiac Dimensions launches pivotal trial for Carillon mitral repair device
Cardiac Dimensions said today it launched a pivotal trial of the Carillon mitral valve repair device it’s developing, and that it enrolled and randomized its first patient in the trial. The Kirkland, Wash.-based company’s percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, to re-form the mitral annulus by bending the coronary sinus. Late last year the FDA granted an investigational device exemption for a 400-patient pivotal trial of the Carillon device. The first patient in the trial was enrolled and ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Replacement Heart Valves Cardiac Dimensions Source Type: news